Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
102 Leser
Artikel bewerten:
(0)

Cardiac Pacemakers - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015

DUBLIN, Ireland, October 7, 2013 /PRNewswire/ --

Dublin- Research and Markets (http://www.researchandmarkets.com/research/d8k3gl/cardiac) has announced the addition of the "Cardiac Pacemakers - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The broad health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.

BRICSS Cardiac Pacemakers market forecasts to reach at US$0.84 billion by 2015 at a CAGR of 12.4% during the analysis period 2009-2015. China accounts for more than 25% of the global value and India claims almost a closer value of the market. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Forecasts of BRICSS External Pacemakers market value indicate approximately 40% while the rest is claimed by Implantable pacemakers sector.

Publication Overview

The report Cardiac Pacemakers - Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 2009-2015' reviews the latest trends in the cardiac pacemakers market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.

The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.

The report primarily focuses on:

- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand Of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies



The report covers the market analysis by product types. The subdivisions are as:

- By Product
a. Implantable Pacemakers (Single-Chamber Pacemakers and Dual-Chamber Pacemakers)
b. External Pacemakers


Examples of Companies Mentioned

- Abbott Vascular Devices
- Abiomed
- Advansource Biomaterials
- Aga Medical Corporation
- Atrium Medical Corp.
- Ats Medical
- Biophan Technologies
- Biosense Webster
- Boston Scientific Corp.
- Cardiac Science Corp.
- Cardiacassist
- Cardica
- Cardiomems
- Cook Group Incorporated
- Cordis Corporation
- Cryolife
- Idev Technologies
- Medtronic



... and many more

For more information visit http://www.researchandmarkets.com/research/d8k3gl/cardiac

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.